ResMed Global General Counsel Sells $102K in Common Stock Under Rule 10b5-1 Plan
RESMED INC
Subscribe to track RMD
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
📢 Insider Transaction Alert: RESMED INC ($RMD) Insider: Rider Michael J (Global General Counsel) Action: Sold 400 shares at $255.00/share (~$102.00K) Date: October 23, 2026 Remaining Holdings: 12,318 shares Plan: Rule 10b5-1 pre-scheduled plan
Comprehensive Analysis
Executive Summary
On October 26, 2026, ResMed Inc. ($RMD) filed a Form 4 disclosing that Michael J. Rider, the company's Global General Counsel, sold 400 shares of common stock on October 23, 2026. The transaction generated total proceeds of $102,000 at an execution price of $255.00 per share.
Transaction Details
- Security: ResMed Common Stock
- Transaction Code: S (Open-market sale)
- Shares Sold: 400 shares
- Execution Price: $255.00
- Total Consideration: $102,000.00
- Ownership After Transaction: 12,318 shares (Direct)
- Trading Plan: Executed pursuant to a Rule 10b5-1 trading plan established on February 28, 2025.
Market & Strategic Context
- Significance Level: Low. The transaction represents approximately 3.1% of Mr. Rider's direct holdings prior to the sale (12,718 shares).
- Programmed Trading: Because this sale was executed under a pre-established Rule 10b5-1 trading plan adopted in February 2025, it does not reflect discretionary timing or opportunistic sentiment regarding the company's near-term outlook.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.